Pharmaceutical Industry Information Portal

HomePharma marketing analytics

Pharma marketing analytics

Novo Nordisk raises 2022 outlook after strong quarter, shares up

Novo Nordisk targets higher sales and operating profit for the year on the back of projected profit growth in the first quarter thanks to...

GSK shows strong sales performance in the first quarter of 2022 – £9.8 billion

British pharmaceutical giant GSK (GSK.L) on Wednesday beat analysts' expectations for its first-quarter results and reaffirmed its 2022 forecast. Highlights Strong sales growth across Biopharma and...

STADA continues to outpace the market in H1 and strengthens basis for further growth

STADA again demonstrated its resilience amid challenging conditions due to the pandemic by outperforming industry trends in the first half of 2021.

Global Intranasal Drug Delivery Market to Reach $59.2 Billion by 2027

In the global Gel segment, USA, Canada, Japan, China and Europe will drive the 3.2% CAGR estimated for this segment.

Top biopharma companies could be affected by Brazilian drug patent suspension

GlaxoSmithKline will be the most affected, as it represents 26% of the potentially impacted drugs. This is followed by Novartis at 14%, Sanofi at 11%, and both Pfizer and Bayer with 8%.

Contract production of pharmaceutical ingredients by 2028 may reach $ 136 billion

The traditional active pharmaceutical ingredient dominated the market and accounted for the largest revenue share of 40.5% in 2020.
spot_img

Expert Articles

spot_img